546 related articles for article (PubMed ID: 15456329)
1. Nabumetone: therapeutic use and safety profile in the management of osteoarthritis and rheumatoid arthritis.
Hedner T; Samulesson O; Währborg P; Wadenvik H; Ung KA; Ekbom A
Drugs; 2004; 64(20):2315-43; discussion 2344-5. PubMed ID: 15456329
[TBL] [Abstract][Full Text] [Related]
2. Nabumetone: a "nonacidic" nonsteroidal antiinflammatory drug.
Dahl SL
Ann Pharmacother; 1993 Apr; 27(4):456-63. PubMed ID: 8477124
[TBL] [Abstract][Full Text] [Related]
3. Nabumetone. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in rheumatic diseases.
Friedel HA; Todd PA
Drugs; 1988 May; 35(5):504-24. PubMed ID: 3293969
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of nabumetone versus diclofenac, naproxen, ibuprofen, and piroxicam in osteoarthritis and rheumatoid arthritis.
Lister BJ; Poland M; DeLapp RE
Am J Med; 1993 Aug; 95(2A):2S-9S. PubMed ID: 8356999
[TBL] [Abstract][Full Text] [Related]
5. Rofecoxib: a review of its use in the management of osteoarthritis, acute pain and rheumatoid arthritis.
Matheson AJ; Figgitt DP
Drugs; 2001; 61(6):833-65. PubMed ID: 11398914
[TBL] [Abstract][Full Text] [Related]
6. [Properties and features of nabumetone].
Davies NM; McLachlan AJ
Drugs; 2000; 59 Spec No 1():25-33. PubMed ID: 10841070
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of nabumetone versus diclofenac, naproxen, ibuprofen, and piroxicam in the elderly.
Morgan GJ; Poland M; DeLapp RE
Am J Med; 1993 Aug; 95(2A):19S-27S. PubMed ID: 8356998
[TBL] [Abstract][Full Text] [Related]
8. Safety experience with nabumetone versus diclofenac, naproxen, ibuprofen, and piroxicam in osteoarthritis and rheumatoid arthritis.
Eversmeyer W; Poland M; DeLapp RE; Jensen CP
Am J Med; 1993 Aug; 95(2A):10S-18S. PubMed ID: 8356997
[TBL] [Abstract][Full Text] [Related]
9. A comparison of adverse renovascular experiences among osteoarthritis patients treated with rofecoxib and comparator non-selective non-steroidal anti-inflammatory agents.
Gertz BJ; Krupa D; Bolognese JA; Sperling RS; Reicin A
Curr Med Res Opin; 2002; 18(2):82-91. PubMed ID: 12017215
[TBL] [Abstract][Full Text] [Related]
10. Clinical pharmacokinetics of nabumetone. The dawn of selective cyclo-oxygenase-2 inhibition?
Davies NM
Clin Pharmacokinet; 1997 Dec; 33(6):404-16. PubMed ID: 9435990
[TBL] [Abstract][Full Text] [Related]
11. Effects of nabumetone compared with naproxen on platelet aggregation in patients with rheumatoid arthritis.
Knijff-Dutmer EA; Martens A; vd Laar MA
Ann Rheum Dis; 1999 Apr; 58(4):257-9. PubMed ID: 10364907
[TBL] [Abstract][Full Text] [Related]
12. [6-methoxy-2-naphthylacetic acid level in plasma, synovial fluid and adjacent tissue in patients with rheumatoid arthritis or gonarthroses after a 4-day therapy with nabumetone (Arthaxan)].
Miehlke RK; Schneider S; Sörgel F; Muth P; Henschke F; Fedder M
Z Rheumatol; 1991; 50(2):103-8. PubMed ID: 1872041
[TBL] [Abstract][Full Text] [Related]
13. Nabumetone. A reappraisal of its pharmacology and therapeutic use in rheumatic diseases.
Friedel HA; Langtry HD; Buckley MM
Drugs; 1993 Jan; 45(1):131-56. PubMed ID: 7680981
[TBL] [Abstract][Full Text] [Related]
14. Safety of the nonselective NSAID nabumetone : focus on gastrointestinal tolerability.
Bannwarth B
Drug Saf; 2008; 31(6):485-503. PubMed ID: 18484783
[TBL] [Abstract][Full Text] [Related]
15. New directions in symptomatic therapy for patients with osteoarthritis and rheumatoid arthritis.
Hochberg MC
Semin Arthritis Rheum; 2002 Dec; 32(3 Suppl 1):4-14. PubMed ID: 12528069
[TBL] [Abstract][Full Text] [Related]
16. Valdecoxib: a review of its use in the management of osteoarthritis, rheumatoid arthritis, dysmenorrhoea and acute pain.
Fenton C; Keating GM; Wagstaff AJ
Drugs; 2004; 64(11):1231-61. PubMed ID: 15161329
[TBL] [Abstract][Full Text] [Related]
17. Comparison of cardiovascular thrombotic events in patients with osteoarthritis treated with rofecoxib versus nonselective nonsteroidal anti-inflammatory drugs (ibuprofen, diclofenac, and nabumetone).
Reicin AS; Shapiro D; Sperling RS; Barr E; Yu Q
Am J Cardiol; 2002 Jan; 89(2):204-9. PubMed ID: 11792343
[TBL] [Abstract][Full Text] [Related]
18. Celecoxib: a review of its use in osteoarthritis, rheumatoid arthritis and acute pain.
Clemett D; Goa KL
Drugs; 2000 Apr; 59(4):957-80. PubMed ID: 10804043
[TBL] [Abstract][Full Text] [Related]
19. Tolerability and efficacy of nabumetone and naproxen in the treatment of rheumatoid arthritis.
Krug H; Broadwell LK; Berry M; DeLapp R; Palmer RH; Mahowald M
Clin Ther; 2000 Jan; 22(1):40-52. PubMed ID: 10688389
[TBL] [Abstract][Full Text] [Related]
20. What have we learned from the large outcomes trials of COX-2 selective inhibitors? The rheumatologist's perspective.
Hochberg MC
Clin Exp Rheumatol; 2001; 19(6 Suppl 25):S15-22. PubMed ID: 11695246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
